Skip to main content

Breadcrumb

  1. Home

Outpatient Services

Colon Cancer: Chemotherapy for AJCC Stage III Colon Cancer Patients

  • Percentage of patients aged 18 years through 80 years with AJCC Stage III colon cancer who are referred for adjuvant chemotherapy, prescribed adjuvant chemotherapy or have previously received adjuvant chemotherapy within the 12-month reporting period

    CBE ID
    0385e

Communication with the physician or other clinician managing on-going care post fracture for men and women aged 50 years and older

  • Percentage of adults 50 years and older treated for a fracture with documentation of communication, between the physician treating the fracture and the physician or other clinician managing the patient’s on-going care, that a fracture occurred and that the patient was or should be considered for osteoporosis treatment or testing. This measure is reported by the physician who treats the fracture and who therefore is held accountable for the communication.

    CBE ID
    0045

Composite weighted average for 3 CT Exam Types: Overall Percent of CT exams for which Dose Length Product is at or below the size-specific diagnostic reference level (for CT Abdomen-pelvis with contrast/single phase scan, CT Chest without contrast/single

  • Measure title continued: Composite weighted average for 3 CT Exam Types: Overall Percent of CT exams for which Dose Length Product is at or below the size-specific diagnostic reference level (for CT Abdomen-pelvis with contrast/single phase scan, CT Chest without contrast/single phase scan and CT Head/Brain without contrast/single phase scan)

    CBE ID
    3621

Comprehensive Diabetes Care

  • The percentage of patients 18–75 years of age with diabetes (type 1 and type 2) who had each of the following:
    - Hemoglobin A1c (HbA1c) testing (NQF#0057)
    - HbA1c poor control (>9.0%) (NQF#0059)
    - HbA1c control (<8.0%) (NQF#0575)
    - HbA1c control (<7.0%) for a selected population*
    - Eye exam (retinal) performed (NQF#0055)
    - LDL-C screening (NQF#0063)
    - LDL-C control (<100 mg/dL) (NQF#0064)
    - Medical attention for nephropathy (NQF#0062)
    - BP control (<140/90 mm Hg) (NQF#0061)
    - Smoking status and cessation advice or treatment

    CBE ID
    0731